{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:13:24Z","timestamp":1793690004564,"version":"4.5.1"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bpobgyn.2024.102573","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T07:40:22Z","timestamp":1734162022000},"page":"102573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Common myths and misconceptions surrounding hormonal contraception"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0030-2431","authenticated-orcid":false,"given":"Kirsten I.","family":"Black","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Vromman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca S.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s13669-017-0205-3","article-title":"Non-contraceptive benefits of hormonal contraception: established benefits and new findings","volume":"6","author":"Brant","year":"2017","journal-title":"Current Obstetrics and Gynecology Reports"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102573_bib2","doi-asserted-by":"crossref","first-page":"e567","DOI":"10.1016\/S2214-109X(20)30060-7","article-title":"Trends in sexual activity and demand for and use of modern contraceptive methods in 74 countries: a retrospective analysis of nationally representative surveys","volume":"8","author":"Slaymaker","year":"2020","journal-title":"Lancet Global Health"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib3","first-page":"83","article-title":"Use of contraception among reproductive-aged women in the United States, 2014 and 2016","volume":"1","author":"Kavanaugh","year":"2020","journal-title":"F S Rep"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102573_bib4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/bmjsrh-2022-201763","article-title":"Contraceptive use and pregnancy planning in Britain during the first year of the COVID-19 pandemic: findings from a large, quasi-representative survey (Natsal-COVID)","volume":"49","author":"Baxter","year":"2023","journal-title":"BMJ Sexual & Reproductive Health"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102573_bib5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/jfprhc-2015-101184","article-title":"A qualitative analysis of women's explanations for changing contraception: the importance of non-contraceptive effects","volume":"42","author":"Wigginton","year":"2016","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102573_bib6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/13625187.2022.2096215","article-title":"Factors influencing contraception choice and use globally: a synthesis of systematic reviews","volume":"27","author":"D'Souza","year":"2022","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102573_bib7","doi-asserted-by":"crossref","first-page":"662.e1","DOI":"10.1016\/j.ajog.2015.08.001","article-title":"Three-year continuation of reversible contraception","volume":"213","author":"Diedrich","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib8","doi-asserted-by":"crossref","first-page":"46.e1","DOI":"10.1016\/j.ajog.2015.01.051","article-title":"The role of contraceptive attributes in women's contraceptive decision making","volume":"213","author":"Madden","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12905-022-01657-6","article-title":"Discontinuation rates of intrauterine contraception due to unfavourable bleeding: a systematic review","volume":"22","author":"Costescu","year":"2022","journal-title":"BMC Wom Health"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.110300","article-title":"Popular contraception videos on TikTok: an assessment of content topics","volume":"129","author":"Stoddard","year":"2024","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40834-024-00262-2","article-title":"Contraceptive content shared on social media: an analysis of Twitter","volume":"9","author":"Huang","year":"2024","journal-title":"Contracept Reprod Med"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib12","series-title":"The guardian","article-title":"TikTok influencers fearmongering about birth control are playing into the hands of the right","author":"Mahdawi","year":"2022"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2021.114247","article-title":"Reasons for rejecting hormonal contraception in Western countries: a systematic review","volume":"284","author":"Le Guen","year":"2021","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jadohealth.2012.04.015","article-title":"An exploratory analysis of associations between eating disordered symptoms, perceived weight changes, and oral contraceptive discontinuation among young minority women","volume":"52","author":"Hall","year":"2013","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2023.116081","article-title":"Interrogating the pill: rising distrust and the reshaping of health risk perceptions in the social media age","volume":"331","author":"Schneider-Kamp","year":"2023","journal-title":"Soc Sci Med"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib16","doi-asserted-by":"crossref","DOI":"10.26443\/mjm.v20i2.886","article-title":"The effect of perceived weight gain on hormonal contraception choice for women: a review","volume":"20","author":"Roberts","year":"2022","journal-title":"McGill J Med"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jpag.2004.01.006","article-title":"Weight gain, adiposity, and eating behaviors among adolescent females on depot medroxyprogesterone acetate (DMPA)","volume":"17","author":"Bonny","year":"2004","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102573_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0010-7824(97)00140-6","article-title":"Depot medroxyprogesterone acetate. Patterns of use and reasons for discontinuation","volume":"56","author":"Paul","year":"1997","journal-title":"Contraception"},{"issue":"10","key":"10.1016\/j.bpobgyn.2024.102573_bib19","first-page":"701","article-title":"Satisfaction, early removal, and side effects associated with long-acting reversible contraception","volume":"45","author":"Dickerson","year":"2013","journal-title":"Fam Med"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/13625187.2015.1137281","article-title":"Non-hormonal and hormonal intrauterine contraception: survey of patients' perceptions in four Latin American countries","volume":"21","author":"Silva-Filho","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102573_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2307\/2135106","article-title":"What do women use when they stop using the pill?","volume":"19","author":"Pratt","year":"1987","journal-title":"Fam Plann Perspect"},{"issue":"8","key":"10.1016\/j.bpobgyn.2024.102573_bib22","first-page":"Cd008815","article-title":"Progestin-only contraceptives: effects on weight","volume":"2016","author":"Lopez","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib23","article-title":"Combination contraceptives: effects on weight","author":"Gallo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib24","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/AOG.0000000000003089","article-title":"Side effects and health benefits of depot medroxyprogesterone acetate: a systematic review","volume":"133","author":"Dianat","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100800","article-title":"Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: findings from a randomised, multicentre, open-label trial","volume":"34","author":"Beksinska","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1590\/2359-3997000000202","article-title":"Body composition, resting energy expenditure and inflammatory markers: impact in users of depot medroxyprogesterone acetate after 12 months follow-up","volume":"61","author":"Batista","year":"2017","journal-title":"Arch Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/archpedi.160.1.40","article-title":"Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method","volume":"160","author":"Bonny","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1083-3188(01)00147-4","article-title":"Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate","volume":"15","author":"Mangan","year":"2002","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib29","series-title":"Proceedings of the symposium on longterm subdermal contraceptive implants","article-title":"Norplant and lactation. The Norplant subdermal contraceptive system","author":"Salem","year":"1984"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2307\/3583465","article-title":"Weight changes in clients on hormonal contraceptives in Zaria, Nigeria","volume":"9","author":"Sule","year":"2005","journal-title":"Afr J Reprod Health"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102573_bib31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.contraception.2013.03.004","article-title":"Weight change at 12 months in users of three progestin-only contraceptive methods","volume":"88","author":"Vickery","year":"2013","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.AOG.0000107298.29343.6a","article-title":"Combination estrogen-progestin contraceptives and body weight: systematic review of randomized controlled trials","volume":"103","author":"Gallo","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102573_bib33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.contraception.2016.12.006","article-title":"Changes in body composition in women using long-acting reversible contraception","volume":"95","author":"Silva Dos Santos","year":"2017","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib34","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/13625187.2015.1079610","article-title":"Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception","volume":"21","author":"Napolitano","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/AOG.0000000000001289","article-title":"Association of progestin contraceptive implant and weight gain","volume":"127","author":"Gallo","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102573_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/13625187.2012.692411","article-title":"Combined oral contraceptives' influence on weight, body composition, height, and bone mineral density in girls younger than 18 years: a systematic review","volume":"17","author":"Warholm","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102573_bib37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/11535450-000000000-00000","article-title":"Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women","volume":"30","author":"Kelly","year":"2010","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2020.556577","article-title":"The effects of hormonal contraceptives on the brain: a systematic review of neuroimaging studies","volume":"11","author":"Br\u00f8nnick","year":"2020","journal-title":"Front Psychol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102573_bib39","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.contraception.2018.01.010","article-title":"The relationship between progestin hormonal contraception and depression: a systematic review","volume":"97","author":"Worly","year":"2018","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102573_bib40","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1192\/bjo.2021.64","article-title":"Hormonal contraceptive use and depressive symptoms: systematic review and network meta-analysis of randomised trials","volume":"7","author":"de Wit","year":"2021","journal-title":"BJPsych Open"},{"issue":"11","key":"10.1016\/j.bpobgyn.2024.102573_bib41","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jamapsychiatry.2016.2387","article-title":"Association of hormonal contraception with depression","volume":"73","author":"Skovlund","year":"2016","journal-title":"JAMA Psychiatr"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9701384","article-title":"The potential of hormonal contraception to influence female sexuality","volume":"2019","author":"de Castro Coelho","year":"2019","journal-title":"Int J Reprod Med"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0010-7824(01)00218-9","article-title":"A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation","volume":"64","author":"Sanders","year":"2001","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.contraception.2009.12.022","article-title":"Effects of sex hormones in oral contraceptives on the female sexual function score: a study in German female medical students","volume":"82","author":"Wallwiener","year":"2010","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102573_bib45","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/humrep\/deh686","article-title":"Effects of two types of hormonal contraception--oral versus intravaginal--on the sexual life of women and their partners","volume":"20","author":"Guida","year":"2005","journal-title":"Hum Reprod"},{"issue":"Suppl 4","key":"10.1016\/j.bpobgyn.2024.102573_bib46","first-page":"S17","article-title":"A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido","volume":"89","author":"Oranratanaphan","year":"2006","journal-title":"J Med Assoc Thai"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102573_bib47","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0010-7824(95)00226-X","article-title":"The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods","volume":"52","author":"Graham","year":"1995","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib48","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0000000000001286","article-title":"Sexual desire and hormonal contraception","volume":"127","author":"Boozalis","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"5 Suppl","key":"10.1016\/j.bpobgyn.2024.102573_bib49","first-page":"391","article-title":"Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception","volume":"41","author":"Nelson","year":"1996","journal-title":"J Reprod Med"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102573_bib50","doi-asserted-by":"crossref","first-page":"545.e1","DOI":"10.1016\/j.ajog.2010.07.024","article-title":"Oral contraceptives vs injectable progestin in their effect on sexual behavior","volume":"203","author":"Schaffir","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102573_bib51","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00404-014-3323-4","article-title":"Sexual life impact evaluation of different hormonal contraceptives on the basis of their methods of administration","volume":"290","author":"Guida","year":"2014","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102573_bib52","first-page":"1059","article-title":"Evaluation of quality of life and sexual functioning of women using levonorgestrel-releasing intrauterine contraceptive system--Mirena","volume":"32","author":"Skrzypulec","year":"2008","journal-title":"Coll Antropol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102573_bib53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/13625187.2019.1639659","article-title":"Concerns on future fertility among users and past-users of combined oral contraceptives: a questionnaire survey","volume":"24","author":"Landersoe","year":"2019","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib54","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bpobgyn.2020.04.003","article-title":"Improving access to and use of contraception by adolescents: what progress has been made, what lessons have been learnt, and what are the implications for action?","volume":"66","author":"Chandra-Mouli","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40834-018-0064-y","article-title":"Return of fertility after discontinuation of contraception: a systematic review and meta-analysis","volume":"3","author":"Girum","year":"2018","journal-title":"Contraception and Reproductive Medicine"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib56","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/humrep\/deh058","article-title":"Is previous use of hormonal contraception associated with a detrimental effect on subsequent fecundity?","volume":"19","author":"Hassan","year":"2004","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102573_bib57","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.fertnstert.2007.05.012","article-title":"Occurrence of menses or pregnancy after cessation of a continuous oral contraceptive","volume":"89","author":"Davis","year":"2008","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib58","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/01443615.2020.1719989","article-title":"Pelvic inflammatory disease among users and non-users of an intrauterine device","volume":"41","author":"Levin","year":"2021","journal-title":"J Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102573_bib59","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.contraception.2011.04.002","article-title":"Fertility after discontinuation of contraception: a comprehensive review of the literature","volume":"84","author":"Mansour","year":"2011","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102573_bib60","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/09513590.2015.1121981","article-title":"Effect of long-term using of hormonal contraception on anti-M\u00fcllerian hormone secretion","volume":"32","author":"Kucera","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/frph.2023.1210083","article-title":"Potential biomarkers to predict return to fertility after discontinuation of female contraceptives-looking to the future","volume":"5","author":"Cordova-Gomez","year":"2023","journal-title":"Front Reprod Health"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102573_bib62","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.fertnstert.2020.11.002","article-title":"Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-Provera","volume":"115","author":"Halpern","year":"2021","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2004.01.011","article-title":"Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera\u00ae","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib64","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(01)00284-0","article-title":"Implantable contraceptives for women: effectiveness, discontinuation rates, return of fertility, and outcome of pregnancies","volume":"65","author":"Glasier","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib65","doi-asserted-by":"crossref","first-page":"62","DOI":"10.13181\/mji.v8i1.950","article-title":"Pregnancy after removal of etonogestrel implant contraceptive (Implanon\u00ae)","volume":"8","author":"Affandi","year":"1999","journal-title":"Medical Journal of Indonesia"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib66","first-page":"304","article-title":"Return of fertility in nulliparous women after discontinuation of the intrauterine device: comparison with women discontinuing other methods of contraception","volume":"108","author":"Doll","year":"2001","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib67","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/ejc.7.1.24.30","article-title":"Return to fertility in nulliparous and parous women after removal of the GyneFix intrauterine contraceptive system","volume":"7","author":"Delbarge","year":"2002","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib68","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.fertnstert.2021.02.007","article-title":"Duration, recency, and type of hormonal contraceptive use and antim\u00fcllerian hormone levels","volume":"116","author":"Bernardi","year":"2021","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib69","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/humrep\/deh058","article-title":"Is previous use of hormonal contraception associated with a detrimental effect on subsequent fecundity?","volume":"19","author":"Hassan","year":"2004","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib70","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.fertnstert.2009.01.003","article-title":"Return to fertility following discontinuation of oral contraceptives","volume":"91","author":"Barnhart","year":"2009","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib71","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/AOG.0b013e3181b46f54","article-title":"Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptives","volume":"114","author":"Cronin","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2024.102573_bib72","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s10815-017-0981-8","article-title":"Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield","volume":"34","author":"Letourneau","year":"2017","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib73","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.appet.2006.09.014","article-title":"You eat what you are: modern health worries and the acceptance of natural and synthetic additives in functional foods","volume":"48","author":"Devcich","year":"2007","journal-title":"Appetite"},{"issue":"sup1","key":"10.1016\/j.bpobgyn.2024.102573_bib74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestogens: influence of different routes of administration","volume":"8","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/13625187.2024.2334350","article-title":"Oestrogens in oral contraception: considerations for tailoring prescription to women's needs","volume":"29","author":"Fruzzetti","year":"2024","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"8","key":"10.1016\/j.bpobgyn.2024.102573_bib76","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/dtb.2014.8.0270","article-title":"Zoely: a new combined oral contraceptive","volume":"52","year":"2014","journal-title":"Drug Ther Bull"},{"issue":"10","key":"10.1016\/j.bpobgyn.2024.102573_bib77","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s40265-022-01738-8","article-title":"Estetrol\/drospirenone: a review in oral contraception","volume":"82","author":"Lee","year":"2022","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib78","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s40268-023-00419-5","article-title":"Estetrol: from preclinical to clinical pharmacology and advances in the understanding of the molecular mechanism of action","volume":"23","author":"G\u00e9rard","year":"2023","journal-title":"Drugs R"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102573_bib79","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/13625187.2017.1334258","article-title":"Women's preferences for menstrual bleeding frequency in 12 European countries: the Inconvenience Due to Women's Monthly Bleeding (ISY) survey","volume":"22","author":"Fiala","year":"2017","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib80","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/jfprhc-2014-100956","article-title":"Hormonal contraception and regulation of menstruation: a study of young women's attitudes towards 'having a period'","volume":"41","author":"Newton","year":"2015","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102573_bib81","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/humrep\/det078","article-title":"Women's experiences with tailored use of a combined oral contraceptive: a qualitative study","volume":"28","author":"Graham","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib82","first-page":"43","article-title":"Unscheduled bleeding and contraceptive choice: increasing satisfaction and continuation rates","volume":"7","author":"Villavicencio","year":"2016","journal-title":"Open Access J Contracept"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib83","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.contraception.2009.02.008","article-title":"Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons","volume":"80","author":"Hubacher","year":"2009","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib84","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12978-020-01054-y","article-title":"A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant","volume":"18","author":"Moray","year":"2021","journal-title":"Reprod Health"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102573_bib85","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ajog.2019.09.044","article-title":"Menstrual bleeding and spotting with the Levonorgestrel Intrauterine System (52 mg) during the first-year after insertion: a systematic review and meta-analysis","volume":"222","author":"Maldonado","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib86","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3332\/ecancer.2022.1416","article-title":"Review of the literature on combined oral contraceptives and cancer","volume":"16","author":"Kamani","year":"2022","journal-title":"Ecancermedicalscience"},{"issue":"23","key":"10.1016\/j.bpobgyn.2024.102573_bib87","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"377","author":"M\u00f8rch","year":"2017","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.bpobgyn.2024.102573_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15235624","article-title":"Hormonal contraception and the risk of breast cancer in women of reproductive age: a meta-analysis","volume":"15","author":"Torres-de la Roche","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004188","article-title":"Combined and progestagen-only hormonal contraceptives and breast cancer risk: a UK nested case\u2013control study and meta-analysis","volume":"20","author":"Fitzpatrick","year":"2023","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib90","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000211368","article-title":"Established and suspected risk factors in breast cancer aetiology","volume":"4","author":"Kluttig","year":"2009","journal-title":"Breast Care"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib91","first-page":"455","article-title":"Dietary influence on breast cancer","volume":"15","author":"Jevtic","year":"2010","journal-title":"J buon"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib92","doi-asserted-by":"crossref","first-page":"k3609","DOI":"10.1136\/bmj.k3609","article-title":"Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study","volume":"362","author":"Iversen","year":"2018","journal-title":"Bmj"},{"issue":"9609","key":"10.1016\/j.bpobgyn.2024.102573_bib93","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib94","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ijc.10696","article-title":"Long-term effects of oral contraceptives on ovarian cancer risk","volume":"102","author":"Bosetti","year":"2002","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.bpobgyn.2024.102573_bib95","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s10552-013-0296-8","article-title":"Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer","volume":"24","author":"Faber","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib96","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2018.02.006","article-title":"Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study","volume":"149","author":"Jareid","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2024.102573_bib97","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1080\/0284186X.2016.1175660","article-title":"Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube","volume":"55","author":"Soini","year":"2016","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102573_bib98","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/01443615.2020.1789960","article-title":"Ever-use of the intra-uterine device and the risk of ovarian cancer","volume":"41","author":"Balayla","year":"2021","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib99","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.annepidem.2021.04.006","article-title":"Association of partner vasectomy, depot medroxyprogesterone acetate and intrauterine contraceptive devices with ovarian cancer","volume":"60","author":"Chesang","year":"2021","journal-title":"Ann Epidemiol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib100","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ijgo.13737","article-title":"Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer","volume":"156","author":"D'Alessandro","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib101","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ajog.2023.03.039","article-title":"Association between intrauterine device use and endometrial, cervical, and ovarian cancer: an expert review","volume":"229","author":"Minalt","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2024.102573_bib102","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1470-2045(15)00212-0","article-title":"Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies","volume":"16","year":"2015","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2024.102573_bib103","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s10654-020-00705-5","article-title":"Oral contraceptive use by formulation and endometrial cancer risk among women born in 1947-1964: the Nurses' Health Study II, a prospective cohort study","volume":"36","author":"Burchardt","year":"2021","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib104","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ygyno.2006.03.046","article-title":"Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk","volume":"103","author":"Maxwell","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ijgo.14846","article-title":"Depot medroxyprogesterone acetate and endometrial cancer: a multicenter case\u2013control study","volume":"163","author":"Kietpeerakool","year":"2023","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102573_bib106","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.3802\/jgo.2023.34.e36","article-title":"Levonorgestrel-releasing intrauterine system-based therapies for early-stage endometrial cancer: a systematic review and meta-analysis","volume":"34","author":"Wei","year":"2023","journal-title":"J Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102573_bib107","first-page":"979","article-title":"Systemic progestins and progestin-releasing intrauterine device therapy for premenopausal patients with endometrial intraepithelial neoplasia","volume":"141","author":"Suzuki","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib108","series-title":"Cancer epidemiology and prevention","author":"Cerhan","year":"2017"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102573_bib109","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ijc.33585","article-title":"Contemporary hormonal contraception and cervical cancer in women of reproductive age","volume":"149","author":"Iversen","year":"2021","journal-title":"Int J Cancer"},{"issue":"9364","key":"10.1016\/j.bpobgyn.2024.102573_bib110","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(03)12949-2","article-title":"Cervical cancer and use of hormonal contraceptives: a systematic review","volume":"361","author":"Smith","year":"2003","journal-title":"Lancet"},{"issue":"9599","key":"10.1016\/j.bpobgyn.2024.102573_bib111","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies","volume":"370","author":"Appleby","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib112","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejca.2019.10.009","article-title":"Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study","volume":"124","author":"Loopik","year":"2020","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib113","first-page":"1","article-title":"Prevalence of high-risk HPV and cervical dysplasia in IUD users and controls: a cross sectional study","author":"Jans","year":"2024","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"11","key":"10.1016\/j.bpobgyn.2024.102573_bib114","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(11)70223-6","article-title":"Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies","volume":"12","author":"Castellsagu\u00e9","year":"2011","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102573_bib115","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/AOG.0000000000002307","article-title":"Intrauterine device use and cervical cancer risk: a systematic review and meta-analysis","volume":"130","author":"Cortessis","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib116","series-title":"Key facts","article-title":"Sexually transmitted infections","year":"2024"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib117","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24601-y","article-title":"Hormonal contraceptive use and the risk of sexually transmitted infections: a systematic review and meta-analysis","volume":"12","author":"Akter","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001778","article-title":"Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis","volume":"12","author":"Morrison","year":"2015","journal-title":"PLoS Med"},{"issue":"10195","key":"10.1016\/j.bpobgyn.2024.102573_bib119","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(19)31288-7","article-title":"HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial","volume":"394","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102573_bib121","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2006.12.018","article-title":"Range of published estimates of venous thromboembolism incidence in young women","volume":"75","author":"Heinemann","year":"2007","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102573_bib122","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/AOG.0b013e318277c93b","article-title":"ACOG Committee Opinion Number 540: risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib123","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int J Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102573_bib124","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/fampra\/14.4.279","article-title":"The impact of the October 1995 'pill scare' on oral contraceptive use in the United Kingdom: analysis of a general practice automated database","volume":"14","author":"Martin","year":"1997","journal-title":"Fam Pract"},{"key":"10.1016\/j.bpobgyn.2024.102573_bib125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.thromres.2018.03.005","article-title":"Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: the role of the progestogen type and estrogen dose","volume":"165","author":"Oedingen","year":"2018","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102573_bib126","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib127","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/AOG.0000000000000411","article-title":"Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes","volume":"124","author":"Bergendal","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2024.102573_bib128","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.bpobgyn.2024.102573_bib129","first-page":"Cd004317","article-title":"Strategies to improve adherence and acceptability of hormonal methods of contraception","author":"Halpern","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib130","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.contraception.2014.04.012","article-title":"What matters most? The content and concordance of patients' and providers' information priorities for contraceptive decision making","volume":"90","author":"Donnelly","year":"2014","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib131","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12875-017-0616-2","article-title":"What do young Australian women want (when talking to doctors about contraception)?","volume":"18","author":"Goldhammer","year":"2017","journal-title":"BMC Fam Pract"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib132","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12978-018-0561-0","article-title":"There might be blood: a scoping review on women's responses to contraceptive-induced menstrual bleeding changes","volume":"15","author":"Polis","year":"2018","journal-title":"Reprod Health"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102573_bib133","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.contraception.2007.05.085","article-title":"Attitudes towards long-acting reversible methods of contraception in general practice in the UK","volume":"76","author":"Wellings","year":"2007","journal-title":"Contraception"},{"issue":"12","key":"10.1016\/j.bpobgyn.2024.102573_bib134","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1093\/humrep\/dem259","article-title":"Misconceptions about oral contraception pills among adolescents and physicians","volume":"22","author":"Hamani","year":"2007","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102573_bib135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12978-017-0380-8","article-title":"Provider and lay perspectives on intra-uterine contraception: a global review","volume":"14","author":"Daniele","year":"2017","journal-title":"Reprod Health"},{"issue":"4, Supplement","key":"10.1016\/j.bpobgyn.2024.102573_bib136","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jadohealth.2013.02.003","article-title":"Myths and misconceptions about long-acting reversible contraception (LARC)","volume":"52","author":"Russo","year":"2013","journal-title":"J Adolesc Health"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102573_bib137","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/humupd\/5.6.627","article-title":"Social consequences. The 'pill scare': the responses of authorities, doctors and patients using oral contraception","volume":"5","author":"Szarewski","year":"1999","journal-title":"Hum Reprod Update"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693424001330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693424001330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T23:00:04Z","timestamp":1740697204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693424001330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":136,"alternative-id":["S1521693424001330"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2024.102573","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Common myths and misconceptions surrounding hormonal contraception","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2024.102573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102573"}}